Total Payments
$568.35
2024 Payments
$107.92
Companies
9
Transactions
37
Medicare Patients
598
Medicare Billing
$46,330
Payment Breakdown by Category
Food & Beverage$568.35 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $568.35 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $347.84 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $50.66 | 3 | $0 (2023) |
| Lilly USA, LLC | $47.73 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $33.98 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $26.88 | 2 | $0 (2023) |
| iRhythm Technologies, Inc. | $18.76 | 1 | $0 (2024) |
| PFIZER INC. | $16.42 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.26 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $11.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.92 | 6 | ABBVIE INC. ($40.75) |
| 2023 | $228.57 | 16 | ABBVIE INC. ($160.76) |
| 2022 | $51.09 | 3 | ABBVIE INC. ($51.09) |
| 2021 | $149.15 | 10 | AbbVie Inc. ($95.24) |
| 2020 | $31.62 | 2 | Astellas Pharma US Inc ($17.36) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Gastroenterology | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Biological | ||||||
| 08/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/05/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: VACCINES | ||||||
| 04/04/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 245 | 278 | $39,081 | $24,191 |
| 2022 | 10 | 201 | 227 | $22,183 | $12,473 |
| 2021 | 6 | 94 | 112 | $13,544 | $6,768 |
| 2020 | 2 | 58 | 68 | $9,582 | $2,898 |
Total Patients
598
Total Services
685
Medicare Billing
$46,330
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $10,322 | $7,350 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 63 | $9,639 | $5,429 | 56.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $6,004 | $4,656 | 77.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $4,200 | $2,399 | 57.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $2,184 | $1,511 | 69.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,055 | $1,161 | 38.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,222 | $763.36 | 62.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $1,034 | $645.92 | 62.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 29 | $1,421 | $276.08 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 52 | $7,956 | $4,135 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $4,266 | $3,396 | 79.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 44 | $4,620 | $2,229 | 48.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,664 | $959.56 | 57.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $752.00 | $419.25 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $682.00 | $360.11 | 52.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 19 | 19 | $475.00 | $321.48 | 67.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $611.00 | $308.57 | 50.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 11 | 11 | $275.00 | $193.29 | 70.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 18 | $882.00 | $150.52 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 31 | $4,743 | $2,333 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $1,896 | $1,544 | 81.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,290 | $1,447 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 28 | $2,940 | $994.29 | 33.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 15 | 15 | $375.00 | $251.58 | 67.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 12 | 12 | $300.00 | $198.16 | 66.1% |
About Dr. Emily George, MD
Dr. Emily George, MD is a Internal Medicine healthcare provider based in Louisville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1093057283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily George, MD has received a total of $568.35 in payments from pharmaceutical and medical device companies, with $107.92 received in 2024. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($568.35).
As a Medicare-enrolled provider, George has provided services to 598 Medicare beneficiaries, totaling 685 services with total Medicare billing of $46,330. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Louisville, OH
- Active Since 03/26/2013
- Last Updated 11/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093057283
Products in Payments
- QULIPTA (Drug) $132.81
- UBRELVY (Drug) $123.69
- VRAYLAR (Drug) $77.45
- XIFAXAN (Drug) $33.98
- JARDIANCE (Drug) $31.01
- MOUNJARO (Drug) $30.98
- MYRBETRIQ (Drug) $29.14
- XARELTO (Drug) $26.88
- Veozah (Drug) $21.52
- ZIO XT Patch (Device) $18.76
- PREVNAR 20 (Biological) $16.42
- LINZESS (Drug) $13.89
- BREZTRI (Drug) $11.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400